Balcinrenone

For research use only. Not for therapeutic Use.

  • CAT Number: I022893
  • CAS Number: 1850385-64-6
  • Molecular Formula: C20H18FN3O5
  • Molecular Weight: 399.37
  • Purity: ≥95%
Inquiry Now

Balcinrenone (Cat No.: I022893) is a synthetic mineralocorticoid receptor antagonist (MRA) developed as part of a new generation of nonsteroidal MRAs. By selectively blocking the mineralocorticoid receptor, it prevents the harmful effects of excess aldosterone, including sodium retention, fibrosis, and inflammation. Balcinrenone has been investigated for its potential in treating cardiovascular and renal diseases, such as hypertension, heart failure, and chronic kidney disease. Compared to earlier MRAs, it offers improved receptor selectivity and a more favorable safety profile, supporting its therapeutic promise.


CAS Number 1850385-64-6
Synonyms

2-[(3S)-7-fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl]-N-methylacetamide

Molecular Formula C20H18FN3O5
Purity ≥95%
InChI InChI=1S/C20H18FN3O5/c1-22-18(25)8-13-9-28-17-7-12(21)3-4-15(17)24(13)20(27)11-2-5-16-14(6-11)23-19(26)10-29-16/h2-7,13H,8-10H2,1H3,(H,22,25)(H,23,26)/t13-/m0/s1
InChIKey MBKYLPOPYYLTNW-ZDUSSCGKSA-N
SMILES CNC(=O)CC1COC2=C(N1C(=O)C3=CC4=C(C=C3)OCC(=O)N4)C=CC(=C2)F
Reference

[1]. Fredrik Erlandsson, et al. Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator. Br J Clin Pharmacol. 2018 Jul;84(7):1486-1493.
[Content Brief]

Chemistry Calculators Dilution Calculator
In vivo Formulation Calculator
Molarity Calculator
Molecular Weight Calculator
Reconstitution Calculator

Request a Quote